4.8 Article

Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

BRAFE600 in benign and malignant human tumours

C. Michaloglou et al.

ONCOGENE (2008)

Article Multidisciplinary Sciences

NMDA antagonist inhibits the extracellular signal-reglulated kinase pathway and suppresses cancer growth

A Stepulak et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Pathology

BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs

CW Wong et al.

JOURNAL OF CLINICAL PATHOLOGY (2005)

Article Neurosciences

Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes

YE Marin et al.

NEUROPHARMACOLOGY (2005)

Article Multidisciplinary Sciences

Mutations of the BRAF gene in human cancer

H Davies et al.

NATURE (2002)

Review Biochemistry & Molecular Biology

Cancer Modeling in the modern era: Progress and challenges

T Van Dyke et al.

Article Multidisciplinary Sciences

Glutamate antagonists limit tumor growth

W Rzeski et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)